Financials
- Market Capitalization 1.82 B
- Employee 47
- Founded 1998
- CEO Helen Sabzevari
- Website www.precigen.com
- Headquarter Virginia, United States
- FIGI BBG000QL8VH9
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2071 | ZYME Zymeworks Inc. - Common Stock | 24.80 USD | +0.57% | -5.78% | +6.44% | +39.80% | 1.81 B USD | ||
| 2076 | RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.38 USD | +1.20% | -7.40% | +3.36% | -36.11% | 1.79 B USD | ||
| 2094 | ZBIO Zenas BioPharma, Inc. - Common Stock | 28.14 USD | -2.22% | +4.73% | +50.00% | +6.35% | 1.78 B USD | ||
| 2117 | IMCR Immunocore Holdings plc - American Depositary Shares | 33.60 USD | +0.39% | +1.94% | +17.44% | +0.36% | 1.71 B USD |